Tavneos for Granulomatosis with Polyangiitis User Reviews
Reviews may be edited to correct grammar/spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest are not published. This information is not intended to endorse any particular medication. While these reviews may be helpful, they are not a substitute for the expertise, knowledge, and judgement of healthcare professionals.
Learn more about Granulomatosis with Polyangiitis
Care guides
Symptoms and treatments
More about Tavneos (avacopan)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: selective immunosuppressants
- Breastfeeding
- En español
"I was a study patient given Tavneos for 12 months. The drug failed to induce remission after 6 months and increased the rate of kidney damage based on my GFR, BUN, and Creatine blood levels. It did cut my prednisone dose by 1.5 mg. The trade off wasn't worth the risk. Be careful, the company is hyping the phase III study data out of context and beyond the FDA approved label"